Drug · DIN 02464489
ESBRIET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 26, 2017; first marketed July 26, 2017.
- Drug Identification Number (DIN)
- 02464489
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pirfenidone L04AX05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PIRFENIDONE | 267 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 2, 2017: NOC 19375Supplement to a New Drug Submission (SNDS) · New dosage form and new manufacturing and testing sites
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “esbriet”. A notice may cover another product or only some lots: read it to see what it covers.
- ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver InjurySeptember 14, 2020 · Drugs · Product safety
Other DINs named ESBRIET
- DIN 02464500 · Marketed
- DIN 02393751 · Cancelled Post Market